Form D · Biotechnology
NanoTomer, Inc.
Boston, MA · CIK 0001779414
Offering snapshot reported Jun 10, 2019 · SEC filing
- Reported sold
- $950K Offering amount: $2M
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- May 28, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 10, 2019 | Initial | $950,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Other
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-341562
Convertible Note
Source: Form D, filed Jun 10, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Bartlett | Executive |
| Jeffrey Bell | Director, Executive |
| Peter Conti | Director |
| David R. Elmaleh | Director |
| Keith Greenfield | Director |
| Robert S. Warren | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
200 Clarendon Street Floor 17
Boston, MA, 02116
Boston, MA, 02116